SEARCH

SEARCH BY CITATION

References

  • 1
    PHLS. The present state of hepatitis A infection in England and Wales. Report of a PHLS working group. Public Health Lab Serv Microbiol Digest 1991;8:122126.
  • 2
    Steffen R. The risk of hepatitis A in travellers. Vaccine 1992;10(Suppl 1):S6972.
  • 3
    Nordenfelt E. Hepatitis A in Swedish travellers. Vaccirve 1992;10(Suppl 1):S7374.
  • 4
    Battegay M, Gust ID, Feinstone S. Hepatitis A virus. In: MandellGL, BennettJB, and DolinR, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 4th Ed. U.S.A. : Churchill Livingstone, 1995:16361656.
  • 5
    Gust ID, Lehmann NI, Lucas CR, et al. Studies on the epidemiology of hepatitis A in Melbourne. In VyasGN, CohnSN, SchmidR, eds. Viral hepatitis. Philadelphia : Franklin Institute Press, 1978:108.
  • 6
    Maynard JE, Bradley DW, Hornbeck CL, et al. Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States. J Infect Dis 1976;134:528530.
  • 7
    Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987;156:8491.
  • 8
    Frosner GG, Roggendorf M, Frosner H-R, et al. Epidemiology of hepatitis A and B infection in Western European countries and in Germans traveling abroad. In: SzmunessW, AlterHJ, MaynardJE, eds. Viral hepatitis, 1981 Internationales Symposium. Philadelphia : Franklin Institute Press, 1981:157168.
  • 9
    Steffen R, Kane MA, Shapiro CN, et al. Epidemiology and prevention of hepatitis A in travellers. JAMA 1994;272:885889.
  • 10
    World Health Organization. Public health control of hepatitis A: memorandum from a WHO meeting. Bull World Health Organ 1995;73:1015.
  • 11
    Centres for Disease Control and Prevention. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers. MMWR 1995;44:559560.
  • 12
    Martin DJ, Blackburn NK, Johnson S, McAnerney JM. Current epidemiology of hepatitis A infection in South Africa; implications for vaccinations. Trans R Soc Trop Med Hyg 1994;88:288291.
  • 13
    Schoub BD, Johnson S, McAnerney J, et al. Exposure to hepatitis B virus among South African health care workers—implications for pre-screening. S Afr Med J 1991;79:2729.
  • 14
    Van Doorslaer E, Tormans G, Van Damme P. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. J Med Virol 1994;44:463469.
  • 15
    Zuckerman JN, Powell L. Hepatitis A antibodies in attenders of London travel clinics: cost-benefit of screening prior to hepatitis A immunisation. J Med Virol 1994;44:393394.
  • 16
    Yao G. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: HollingerFB, LemonSM, MargolisHS, eds. Viral hepatitis and liver disease. Baltimore : Williams and Wilkins, 1991:7678.
  • 17
    Steffen R. Epidemiologic studies of travellers' diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis 1986;8 (Suppl 2S):S122S130.